Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
92,893,700
-
Share change
-
+695,161
-
Total reported value
-
$12,808,484,013
-
Put/Call ratio
-
68%
-
Price per share
-
$137.92
-
Number of holders
-
578
-
Value change
-
+$99,362,674
-
Number of buys
-
302
-
Number of sells
-
253
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2024
As of 31 Mar 2024 NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) had 578 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 92,893,700 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, JPMORGAN CHASE & CO, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, Bellevue Group AG, PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, and JANUS HENDERSON GROUP PLC.
This table shows 579 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.